You are here

Novo Nordisk

Novo builds heart failure case for semaglutide

BioPharma Dive

Fri, 08/30/24 - 11:31 am

cardiovascular disease

Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145B Annually: Study

BioSpace

Tue, 08/27/24 - 11:32 am

cardiovascular disease

Ozempic on Wall Street's list for 2027 Medicare drug negotiations

Reuters

Fri, 08/23/24 - 10:59 am

Does Ozempic increase the risk of suicidal thoughts? A new study muddles the picture

Stat

Tue, 08/20/24 - 11:11 am

suicidal ideation

Novo Nordisk to build $220 mln raw materials plant in Denmark

Reuters

Fri, 08/16/24 - 11:20 am

Novo Nordisk Pharmatech

drug manufacturing

Doctors struggle to get Wegovy for older Americans with heart disease

Reuters

Thu, 08/15/24 - 11:41 am

5 Obesity Readouts to Watch in the Second Half of 2024

BioSpace

Tue, 08/13/24 - 11:47 am

clinical trials

Terns Pharmaceuticals

Novo Nordisk plots 2024 FDA filing for once-weekly insulin and semaglutide combo

Fierce Pharma

Mon, 08/12/24 - 06:01 pm

Weight-loss drugs like Wegovy may help stave off some cancers

NPR

Mon, 08/12/24 - 11:28 am

Pharma execs react to final drug price negotiations with Medicare

Pharma Voice

Fri, 08/9/24 - 11:21 am

Inflation Reduction Act

Bristol Myers Squibb

Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half

Pharma Voice

Thu, 08/8/24 - 11:07 am

Novo Nordisk pulls its FDA heart failure submission for Wegovy, will reapply early next year

Fierce Pharma

Wed, 08/7/24 - 11:47 am

Novo Nordisk’s GLP-1 sales surge, but Q2 earnings disappoint

Medical Marketing and Media

Wed, 08/7/24 - 11:45 am

Access is unequal to weight-loss drugs Ozempic and Wegovy: study

Axios

Mon, 08/5/24 - 11:08 am

Novo Nordisk launches weight-loss drug Wegovy in Australia

Reuters

Thu, 08/1/24 - 11:11 pm

Novo Loses IRA Case as NJ Judge Asserts Price Negotiations Are Voluntary

BioSpace

Thu, 08/1/24 - 11:41 am

Inflation Reduction Act

Oxford Nanopore rises on Novo Holdings equity stake

Pharmaphorum

Thu, 08/1/24 - 11:09 am

Oxford Nanopore

Patients push back against Novo Nordisk move to scrap an insulin product

Reuters

Tue, 07/30/24 - 06:37 pm

long-acting insulin

Novo’s Older GLP-1 Drug Slows Cognitive Decline in Phase IIb Alzheimer’s Trial

BioSpace

Tue, 07/30/24 - 11:48 am

clinical trials

Alzheimer's disease

Pages